bpc-157 safety concerns regulatory status fda warning The Food and Drug Administration's committee on compounded drugs broke with agency scientists and voted in favor of adding peptides to the list of substances compounding pharmacies can make. Follow the link FDA to discuss easing restrictions

FDA to discuss easing restrictions on peptides despite safety concerns US healthcare The Guardian A panel of advisers to the U.S. Food and Drug Administration on Thursday began weighing whether it should loosen regulations on seven peptides, the increasingly popular compounded medicines backed by social media This week, the U.S. Food and Drug Administration is reviewing seven peptides after they were banned three years ago over safety concernsa move championed by Health and Human Services Secretary Robert F. FDA scientists flag concerns with peptides as RFK Jr. tries to ease access : NPR

SKU: 424633017 · From www.asociacionchamorro.org